fulvestrant has been researched along with 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, EP; Grass, L; Luo, LY | 1 |
1 other study(ies) available for fulvestrant and 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile
| Article | Year |
|---|---|
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Topics: Aldosterone; Androgen Antagonists; Cell Line; Cell Line, Tumor; Chloramphenicol O-Acetyltransferase; Cloning, Molecular; Dexamethasone; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Imidazoles; Kallikreins; Kinetics; Mifepristone; Nitriles; Norgestrel; Promoter Regions, Genetic; Recombinant Fusion Proteins; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Up-Regulation | 2003 |